Daiken Biomedical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	2,024	1,895	1,362	1,190	884.97
Revenue Growth (YoY)	39.00%	39.10%	14.45%	34.52%	-
Cost of Revenue	762.71	689.36	506.17	376.66	271.66
Gross Profit	1,261	1,206	856.22	813.76	613.3
Selling, General & Admin	937.5	906.21	696.26	601.78	493.5
Research & Development	10.33	11.28	10.16	7.82	7.36
Operating Expenses	947.85	917.52	707.3	609.61	500.87
Operating Income	313.6	288.21	148.92	204.15	112.44
Interest Expense	-1.41	-0.6	-6	-3.36	-1.18
Interest & Investment Income	68.43	32.89	28.43	2.87	0.2
Currency Exchange Gain (Loss)	7.28	7.28	-31.85	-8.39	-1.92
Other Non Operating Income (Expenses)	38.74	89.69	0.11	0.08	0.01
Pretax Income	426.64	417.48	139.6	195.35	109.54
Income Tax Expense	89.42	79.62	33.02	35	19.36
Net Income	337.22	337.87	106.58	160.35	90.17
Net Income to Common	337.22	337.87	106.58	160.35	90.17
Net Income Growth	38.99%	217.01%	-33.53%	77.83%	-
Shares Outstanding (Basic)	810	667	439	224	155
Shares Outstanding (Diluted)	810	668	439	225	156
Shares Change (YoY)	51.92%	52.12%	95.20%	44.34%	-
EPS (Basic)	0.42	0.51	0.24	0.72	0.58
EPS (Diluted)	0.42	0.51	0.24	0.71	0.58
EPS Growth	-8.59%	110.95%	-66.34%	23.14%	-
Free Cash Flow	299.35	272.21	50.5	105.21	41.58
Free Cash Flow Per Share	0.37	0.41	0.12	0.47	0.27
Dividend Per Share	0.480	0.698	0.404	0.486	0.417
Dividend Growth	-22.87%	72.88%	-16.87%	16.55%	-
Gross Margin	62.32%	63.62%	62.85%	68.36%	69.30%
Operating Margin	15.49%	15.21%	10.93%	17.15%	12.71%
Profit Margin	16.66%	17.83%	7.82%	13.47%	10.19%
Free Cash Flow Margin	14.79%	14.36%	3.71%	8.84%	4.70%
EBITDA	320.82	295.16	153.13	205.07	112.54
EBITDA Margin	15.85%	15.57%	11.24%	17.23%	12.72%
D&A For EBITDA	7.22	6.95	4.21	0.92	0.1
EBIT	313.6	288.21	148.92	204.15	112.44
EBIT Margin	15.49%	15.21%	10.93%	17.15%	12.71%
Effective Tax Rate	20.96%	19.07%	23.65%	17.91%	17.68%
Advertising Expenses	-	450.14	380.08	383.45	329.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.